Event-free survival as a surrogate endpoint for overall survival in previously untreated acute myeloid leukemia: An individual patient-level analysis of multiple randomized trials (Alliance A151614)
      Google Scholar   
Citation:
Blood vol 132 (Suppl 1) 1386
Meeting Instance:
ASH 2018
Year:
2018
Type:
Abstract
Sub type:
Poster General
Funding:
NCTN
Endpoint:
Primary
Analysis:
Comprehensive
Data Sharing:
No-Data-Sharing
Status:
Presented/Published
Citation Status:
epreprint
Note:
Methodological:
No
Biospecimen:
No
SDC:
Yes
Parents:
None
Children:
2887  
Program:
OGC
Primary Committee:
Leukemia
Sec. Committees:
   
Pharmas:
Novartis  
Grants:
U10CA180821, U10CA180882, U10CA180794, U10CA180820, U10CA180888  
Corr. Author:
 
Authors:
                             
Networks:
CA043, FL023, LAPS-IL057, LAPS-MA036, LAPS-MN026, LAPS-MO011, LAPS-OH007   
Study
Alliance-A151614
Multiple Studies, or Legacy Studies in Alliance Study:
CALGB-10201, ECOG-E1900, CALGB-10603, SWOG-S0106
Phases:
N/A, 3
Keywords: